ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20.

Saved in:
Bibliographic Details
Title: ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20.
Authors: Locke, Kenneth W.1 (AUTHOR) klocke@halozyme.com, Maneval, Daniel C.1 (AUTHOR), LaBarre, Michael J.1 (AUTHOR)
Source: Drug Delivery. Dec2019, Vol. 26 Issue 1, p98-106. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10717544
DOI:10.1080/10717544.2018.1551442